Nordson Corporation
NDSN · What the business does, what can go wrong, and how options sellers approach it
What it does
Nordson makes precision equipment that dispenses, controls and tests materials such as adhesives, coatings, sealants and plastics. Its products include pumps, valves, dispensers, applicators, filters and pelletizers.
The company reports in three segments: industrial precision solutions, medical and fluid solutions, and advanced technology solutions. Its customers span packaging, medical, electronics and general industrial markets.
How it makes money
Nordson sells equipment and also sells the parts and consumables that go with it, such as nozzles, tips and replacement components. Equipment sales tend to follow customer investment cycles. Consumables and service tend to be steadier because they are used as long as the customer's production lines keep running.
The company also grows by acquiring smaller technology businesses and folding them into its segments.
Why investors own it
Investors often see Nordson as a quality industrial. Its equipment is built into customers' production processes, which can make it costly to replace. The recurring consumables stream may add stability. Exposure to several end markets means no single industry has to carry the whole business. Some investors also value its record of returning cash through dividends, though payouts are never guaranteed.
What can go wrong
- Electronics and semiconductor-related demand can be cyclical, and weak spending hits equipment orders.
- Acquisitions can be overpriced or hard to integrate.
- A strong U.S. dollar can reduce reported results, because much of the business is international.
- Customers may delay capital purchases when economic conditions or interest rates worsen.
- Premium valuations, when they exist, can leave a stock vulnerable to disappointment.
What to watch
- Organic sales growth by segment
- Order backlog and order trends
- Operating margin
- Share of recurring consumables and service revenue
- Currency effects on results
- Acquisition activity and debt levels
- Capital spending trends in electronics and packaging
Options income angle
Options on NDSN exist across several expirations, but trading is generally thinner than for large, widely held megacap stocks. Wider bid-ask spreads can make entering and exiting positions more costly, especially for strikes far from the current price.
Implied volatility tends to rise ahead of quarterly earnings and when investors worry about industrial or semiconductor demand. It often settles after results are released.
One caution for premium sellers: a sharp earnings-related move can quickly overwhelm the premium collected. Covered calls can also cap gains if the stock rallies, and cash-secured puts can mean owning shares after a sizable drop.
What the latest 10-K says
A plain-English read of the Risk Factors and Management's Discussion in the 10-K for the year ended October 31, 2025, filed December 17, 2025. Figures are as the filing reports them. Read the filing on SEC.gov
The filing in brief
Nordson's fiscal 2025 sales were $2,791,687 thousand, up 3.8 percent, and net income was $484,474 thousand, up 3.7 percent. Acquisitions drove the growth, since organic sales (which strip out acquisitions, divestitures and currency) fell 2.5 percent. The company also exited its medical contract manufacturing business and put most of its cash flow toward share buybacks, debt paydown and dividends.
How the business did
- Operating profit was $711,725 thousand, up 5.6 percent. Diluted earnings per share were $8.51, against $8.11 the year before. Gross margin held at 55.2 percent. The effective tax rate fell to 18.9 percent from 20.2 percent, which the filing attributes to a decline in federal valuation allowances.
- Industrial Precision Solutions (IPS) sales were $1,331,792 thousand, with organic sales down 5.1 percent on weakness in polymer processing and industrial coatings. Medical and Fluid Solutions (MFS) sales were $835,385 thousand, up 20.1 percent in total, with acquisitions adding 23.0 percent. Advanced Technology Solutions (ATS) organic sales rose 4.1 percent on electronics dispense products, partly offset by weak x-ray inspection systems.
- Cash from operations was $719,175 thousand, against $556,193 thousand in 2024. The company repurchased over $300 million of shares, reduced debt by approximately $224 million and paid $179 million in dividends.
- Unusual items: divestiture and related charges of $12,545 thousand tied to exiting medical contract manufacturing, and higher interest expense from debt that funded acquisitions.
Risks specific to this company
- Trade policy: Approximately 67 percent of 2025 revenue came from outside the United States. The filing singles out tariffs involving Canada, China and Mexico, and says they could hurt sales, margins and supplier relationships.
- Currency: Exposure is mainly to the euro, the yen, the pound sterling and the Chinese yuan. Hedging may not fully protect results.
- Cyclical end markets: Electronics, polymer processing, agriculture and metal finishing have historically been cyclical. Polymer processing was already a drag on IPS this year.
- Acquisition reliance and goodwill: Growth depends partly on buying and integrating companies, and the filing names the integration of Atrion. Goodwill is the excess paid over the fair value of what was acquired. MFS had the smallest cushion of the three segments, with fair value 132 percent above carrying value, on goodwill of $1,661,150 thousand.
- Debt terms: Credit facilities carry covenants, including a Leverage Ratio and an Interest Coverage Ratio. The $300,000 thousand term loan matures in June 2026, with $265,000 thousand outstanding. The company says it was in compliance with all covenants.
- Input costs: Raw material and component price increases have historically reached customer prices only after a delay, and competition may block them entirely.
What management is watching
- Tariffs and other trade rules. The MD&A says they could hurt operating cash flow and liquidity in future periods. No numeric outlook for next year appears in these sections.
- Integrating Atrion and divesting businesses that do not fit the strategic plan. Severance and other cost-reduction charges were $19,256 thousand.
- Segment EBITDA (earnings before interest, taxes, depreciation and amortization), which management uses to report segment profit. Total segment EBITDA was $952,146 thousand, or 34.1 percent of sales. Organic sales growth is the other measure the filing returns to.
- Liquidity. Available borrowings and unused credit lines totaled $935,151 thousand. Management calls cash on hand, operating cash flow and borrowing capacity more than adequate for the next twelve months and beyond.
- Spending priorities: capital projects for organic growth, dividends, share repurchases, debt repayment and pension contributions.
What the latest 10-Q says
A plain-English read of Management's Discussion (and any new or changed risk factors) in the 10-Q for the quarter ended July 31, 2026, filed August 20, 2026. Figures are as the filing reports them. Read the filing on SEC.gov
The quarter in brief
Nordson reported sales of $817,667 thousand for the three months ended July 31, 2026, up 10.3 % from the prior year. Net income rose 21.5 %. The Advanced Technology Solutions (ATS) segment drove the growth, while the Industrial Precision Solutions (IPS) segment grew sales but earned a lower margin.
How the business did
- Quarter results: Operating profit was $223,092 thousand versus $187,767 thousand a year earlier. Diluted earnings per share were $2.73 versus $2.22. Gross margin was 55.5 % versus 54.8 %. Management credited higher operating profit, lower interest expense and share repurchases. Last year's quarter also included $12,211 thousand of divestiture charges that did not recur.
- Segments: Organic sales (growth excluding acquisitions, divestitures and currency) rose 30.9 % at ATS, on electronics dispense and test and inspection products. They rose 10.6 % at Medical and Fluid Solutions (MFS) and 3.3 % at IPS. By region, Asia Pacific organic sales grew 24.1 %.
- Margins by segment: Segment EBITDA (earnings before interest, taxes, depreciation and amortization) margin rose 560 basis points at ATS (a basis point is one hundredth of a percentage point). It rose 40 basis points at MFS and fell 170 basis points at IPS. Management blamed IPS's decline on investment in innovation and select near-term inflationary pressures.
- Unusual items: Other expense for the quarter included unrealized losses on minority investments of $14,892 thousand. For the nine months, the company booked a $24,049 thousand pension settlement charge after using plan assets to buy a group annuity contract from RGA.
- Cash and capital return: Nine-month operating cash flow was $570,473 thousand versus $516,264 thousand. The company repaid $258 million of debt, repurchased $159 million of common shares and paid $137 million in dividends. At quarter end, $192 million of commercial paper was outstanding, and nothing was drawn on the revolving credit facility.
What management is watching
- The filing gives no numeric outlook for the rest of the year. Management says cash from operations and available borrowing should be more than adequate to meet liquidity needs over the next twelve months and beyond.
- Management says international conflicts, changes in trade policy, tariffs and import/export rules could hurt cash flow and liquidity in future periods.
- Spending priorities named are innovation, capital projects to drive organic growth, dividends, and share repurchases. Additions to property, plant and equipment were $40,313 thousand for the nine months.
- Management points to organic sales growth and segment EBITDA margins as its main yardsticks for how each business is performing.
Follow NDSN in Kortex
The Kortex app shows NDSN's price, options chain and IV rank, and answers your questions from live market data and SEC filings.
Free to download.
Learn the strategies
More stock briefs
For education only, not financial advice. Options involve risk and are not suitable for every investor.